406 related articles for article (PubMed ID: 20538915)
1. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion.
Li P; Burke S; Wang J; Chen X; Ortiz M; Lee SC; Lu D; Campos L; Goulding D; Ng BL; Dougan G; Huntly B; Gottgens B; Jenkins NA; Copeland NG; Colucci F; Liu P
Science; 2010 Jul; 329(5987):85-9. PubMed ID: 20538915
[TBL] [Abstract][Full Text] [Related]
2. Immunology. A guardian of T cell fate.
Di Santo JP
Science; 2010 Jul; 329(5987):44-5. PubMed ID: 20595605
[No Abstract] [Full Text] [Related]
3. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b.
Li L; Leid M; Rothenberg EV
Science; 2010 Jul; 329(5987):89-93. PubMed ID: 20595614
[TBL] [Abstract][Full Text] [Related]
4. An essential developmental checkpoint for production of the T cell lineage.
Ikawa T; Hirose S; Masuda K; Kakugawa K; Satoh R; Shibano-Satoh A; Kominami R; Katsura Y; Kawamoto H
Science; 2010 Jul; 329(5987):93-6. PubMed ID: 20595615
[TBL] [Abstract][Full Text] [Related]
5. A new avenue to cure cancer by turning adaptive immune T cells to innate immune NK cells via reprogramming.
Su DM; Vankayalapati R
J Mol Cell Biol; 2010 Oct; 2(5):237-9. PubMed ID: 20693167
[TBL] [Abstract][Full Text] [Related]
6. Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy.
Geng JJ; Tang J; Yang XM; Chen R; Zhang Y; Zhang K; Miao JL; Chen ZN; Zhu P
EBioMedicine; 2017 Jun; 20():98-108. PubMed ID: 28571672
[TBL] [Abstract][Full Text] [Related]
7. Chimeric antigen receptor-induced BCL11B suppression propagates NK-like cell development.
Maluski M; Ghosh A; Herbst J; Scholl V; Baumann R; Huehn J; Geffers R; Meyer J; Maul H; Eiz-Vesper B; Krueger A; Schambach A; van den Brink MR; Sauer MG
J Clin Invest; 2019 Dec; 129(12):5108-5122. PubMed ID: 31479431
[TBL] [Abstract][Full Text] [Related]
8. Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment.
Kueh HY; Yui MA; Ng KK; Pease SS; Zhang JA; Damle SS; Freedman G; Siu S; Bernstein ID; Elowitz MB; Rothenberg EV
Nat Immunol; 2016 Aug; 17(8):956-65. PubMed ID: 27376470
[TBL] [Abstract][Full Text] [Related]
9. TNF-α-dependent hematopoiesis following Bcl11b deletion in T cells restricts metastatic melanoma.
Uddin MN; Zhang Y; Harton JA; MacNamara KC; Avram D
J Immunol; 2014 Feb; 192(4):1946-53. PubMed ID: 24446520
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation.
Holmes TD; Pandey RV; Helm EY; Schlums H; Han H; Campbell TM; Drashansky TT; Chiang S; Wu CY; Tao C; Shoukier M; Tolosa E; Von Hardenberg S; Sun M; Klemann C; Marsh RA; Lau CM; Lin Y; Sun JC; Månsson R; Cichocki F; Avram D; Bryceson YT
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33712472
[TBL] [Abstract][Full Text] [Related]
11. Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytes.
Kastner P; Chan S; Vogel WK; Zhang LJ; Topark-Ngarm A; Golonzhka O; Jost B; Le Gras S; Gross MK; Leid M
Eur J Immunol; 2010 Aug; 40(8):2143-54. PubMed ID: 20544728
[TBL] [Abstract][Full Text] [Related]
12. Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity.
Liu P; Li P; Burke S
Immunol Rev; 2010 Nov; 238(1):138-49. PubMed ID: 20969590
[TBL] [Abstract][Full Text] [Related]
13. CD5
Hatano S; Murakami T; Noguchi N; Yamada H; Yoshikai Y
Cell Rep; 2017 Oct; 21(5):1191-1202. PubMed ID: 29091759
[TBL] [Abstract][Full Text] [Related]
14. Molecular dissection of prethymic progenitor entry into the T lymphocyte developmental pathway.
Tydell CC; David-Fung ES; Moore JE; Rowen L; Taghon T; Rothenberg EV
J Immunol; 2007 Jul; 179(1):421-38. PubMed ID: 17579063
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes.
Albu DI; VanValkenburgh J; Morin N; Califano D; Jenkins NA; Copeland NG; Liu P; Avram D
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6211-6. PubMed ID: 21444811
[TBL] [Abstract][Full Text] [Related]
16. Bcl11b prevents fatal autoimmunity by promoting T
Drashansky TT; Helm E; Huo Z; Curkovic N; Kumar P; Luo X; Parthasarathy U; Zuniga A; Cho JJ; Lorentsen KJ; Xu Z; Uddin M; Moshkani S; Zhou L; Avram D
Sci Adv; 2019 Aug; 5(8):eaaw0480. PubMed ID: 31457080
[TBL] [Abstract][Full Text] [Related]
17. Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner.
Hirose S; Touma M; Go R; Katsuragi Y; Sakuraba Y; Gondo Y; Abe M; Sakimura K; Mishima Y; Kominami R
Int Immunol; 2015 Apr; 27(4):205-15. PubMed ID: 25422283
[TBL] [Abstract][Full Text] [Related]
18. RORα is a critical checkpoint for T cell and ILC2 commitment in the embryonic thymus.
Ferreira ACF; Szeto ACH; Heycock MWD; Clark PA; Walker JA; Crisp A; Barlow JL; Kitching S; Lim A; Gogoi M; Berks R; Daly M; Jolin HE; McKenzie ANJ
Nat Immunol; 2021 Feb; 22(2):166-178. PubMed ID: 33432227
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA-seq identifies a PD-1
Yu Y; Tsang JC; Wang C; Clare S; Wang J; Chen X; Brandt C; Kane L; Campos LS; Lu L; Belz GT; McKenzie AN; Teichmann SA; Dougan G; Liu P
Nature; 2016 Nov; 539(7627):102-106. PubMed ID: 27749818
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development.
Yu Y; Wang C; Clare S; Wang J; Lee SC; Brandt C; Burke S; Lu L; He D; Jenkins NA; Copeland NG; Dougan G; Liu P
J Exp Med; 2015 Jun; 212(6):865-74. PubMed ID: 25964371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
